Research


Financing Drug Discovery via Dynamic Leverage

with Vahid Montazerhodjat and John J. Frishkopf, Drug Discovery Today 21(2016), 410–414.

View abstract

Is the FDA Too Conservative or Too Aggressive?: A Bayesian Decision Analysis of Clinical Trial Design

with Leah Isakov and Vahid Montazerhodjat

View abstract

Lessons From Hollywood: A New Approach To Funding R&D

with Gary P. Pisano, Sloan Management Review 57(2015), 47–57.

View abstract

Megafunding Drug Research

with Edward Jung, Project Syndicate

View abstract

FAQs for Megafund Financing

with Jose Maria Fernandez and Roger M. Stein

View abstract

Funding Translational Medicine via Public Markets: The Business Development Company

with Sandra M. Forman, Monica Shilling, Grace K. Sweeney, Journal of Investment Management 13(2015), 9–32.

View abstract

Financing Translation: Analysis of the NCATS Rare-Diseases Portfolio

with David E. Fagnan, N. Nora Yang, John C. McKew, Science Translational Medicine 7(2015), 276ps3.

View abstract

Financing Drug Discovery for Orphan Diseases

with David E. Fagnan, Austin A. Gromatzky, Jose-Maria Fernandez, Roger M. Stein, Drug Discovery Today 19 (2014), 533-538

View abstract

Wall Street’s Next Bet: Cures for Rare Diseases

Fortune

View abstract

New Financing Methods in the Biopharma Industry: A Case Study of Royalty Pharma, Inc.

with Sourya V. Naraharisetti, Journal of Investment Management

View abstract

Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design